Publication | Closed Access

Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone

Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicinePathologyWell-differentiated Lymphocytic LymphomaAdult T-cell Leukemia-lymphomaIntermittent High-dose PrednimustineOncology